Company Filing History:
Years Active: 2006-2015
Title: Inventor Ana Cristina Fernandes: Pioneering Carbon Monoxide-Releasing Compounds
Introduction
Ana Cristina Fernandes, an innovative inventor from Amadora, Portugal, has made significant strides in the field of pharmaceuticals. With three patents to her name, Fernandes focuses on the development of compounds that leverage the therapeutic benefits of carbon monoxide to treat various chronic and inflammatory diseases.
Latest Patents
Among her notable inventions is a method for treating mammals through the administration of a compound capable of releasing carbon monoxide (CO). This innovative approach holds promise for the treatment and prevention of diseases characterized by chronic inflammation, such as rheumatoid arthritis. Additionally, it addresses conditions with a strong inflammatory component, including atherosclerosis, stroke, coronary disease, and Alzheimer's disease. The versatility of these in vivo carbon monoxide-releasing compounds allows them to be linked with established drug vectors and anti-inflammatory medications, such as aspirin.
Career Highlights
Ana has contributed her expertise to various companies dedicated to pharmaceutical research and development. Notably, she was involved with Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos, Lda., which has enabled her to further refine her inventions and bring innovative solutions to the healthcare industry.
Collaborations
Throughout her career, Fernandes has collaborated with esteemed professionals, including Werner E. Haas and Carlos C. Romão. These partnerships have not only enriched her research but have also fostered an environment of shared knowledge in the pursuit of advancing medical science and therapeutic techniques.
Conclusion
Ana Cristina Fernandes exemplifies the spirit of innovation through her work on carbon monoxide-releasing compounds. Her patents reflect a commitment to advancing treatments for serious health conditions, ultimately contributing to the improvement of patient care and quality of life. With her continued research and dedication, Fernandes remains a key figure in the evolving landscape of pharmaceutical innovation.